Customize your search results with filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 02/19/2023

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 591 publications

Feasibility and Safety of a Powered Exoskeleton for Balance Training for People Living with Multiple Sclerosis: A Single-Group Preliminary Study (Rapper III).

Condition: Adults with Multiple Sclerosis
Journal: Journal of rehabilitation medicine
Treatment Used: Rex Rehab Exoskeleton Device
Number of Patients: 11
Published: December 09, 2022

The ULTIMATE trials: are there advantages of ublituximab over teriflunomide in relapsing multiple sclerosis?

Condition: Multiple Sclerosis (MS)
Journal: Expert opinion on biological therapy
Treatment Used: Ublituximab vs. Teriflunomide
Number of Patients: 0
Published: November 01, 2022

The Efficacy and Safety of Anti-CD20 Antibody Treatments in Relapsing Multiple Sclerosis: A Systematic Review and Network Meta-analysis.

Condition: Relapsing Multiple Sclerosis
Journal: CNS drugs
Treatment Used: Anti-CD20 Antibody Treatments
Number of Patients: 4181
Published: October 16, 2022

The Efficacy and Safety of Manual Therapy for Symptoms Associated with Multiple Sclerosis: A Systematic Review and Meta-Analysis.

Condition: Multiple Sclerosis (MS)
Journal: Journal of integrative and complementary medicine
Treatment Used: Manual Therapy
Number of Patients: 631
Published: October 07, 2022

Pediatric therapeutic options in autoimmune neurologic diseases.

Condition: Pediatric Autoimmune Neurological Diseases
Journal: Medicina
Treatment Used: Steroids, Immunoglobulin, or Plasmapheresis
Number of Patients: 0
Published: September 02, 2022

An exposure-response analysis of ponesimod clinical efficacy in a randomized phase III study in patients with relapsing multiple sclerosis.

Condition: Relapsing Multiple Sclerosis (MS)
Journal: CPT: pharmacometrics & systems pharmacology
Treatment Used: Ponesimod
Number of Patients: 0
Published: September 01, 2022

Disease stability over five years in people with multiple sclerosis treated with cladribine tablets: a plain language summary.

Condition: Multiple Sclerosis (MS)
Journal: Neurodegenerative disease management
Treatment Used: Cladribine
Number of Patients: 0
Published: August 26, 2022

Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis.

Condition: Relapsing Multiple Sclerosis
Journal: The New England journal of medicine
Treatment Used: Ublituximab
Number of Patients: 549
Published: August 24, 2022

The effect of cladribine tablets in people with more active multiple sclerosis: a plain language summary.

Condition: Multiple Sclerosis (MS)
Journal: Neurodegenerative disease management
Treatment Used: Cladribine
Number of Patients: 0
Published: August 03, 2022

A real world multi center study on efficacy and safety of natalizumab in Indian patients with multiple sclerosis.

Condition: Indian Patients with Multiple Sclerosis (MS)
Journal: Multiple sclerosis and related disorders
Treatment Used: Natalizumab (NTZ)
Number of Patients: 116
Published: July 31, 2022

Comparative Efficacy of Relapsing Multiple Sclerosis Therapies: Model-Based Meta-Analyses for Confirmed Disability Accumulation and Annualized Relapse Rate.

Condition: Relapsing Multiple Sclerosis (RMS)
Journal: Multiple sclerosis and related disorders
Treatment Used: Ponesimod and Other Disease-Modifying Therapies (DMTs)
Number of Patients: 31160
Published: July 08, 2022

Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Up to 5 years of follow-up in the DAYBREAK open-label extension trial.

Condition: Relapsing Multiple Sclerosis (MS)
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Treatment Used: Ozanimod
Number of Patients: 2494
Published: June 29, 2022
Showing 1-12 of 591

Last Updated: 02/19/2023